Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Liabilities and Shareholders Equity (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Liabilities and Shareholders Equity for 4 consecutive years, with $1.4 billion as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Liabilities and Shareholders Equity changed 0.23% year-over-year to $1.4 billion, compared with a TTM value of $2.7 billion through Dec 2024, changed 0.39%, and an annual FY2024 reading of $1.4 billion, changed 0.23% over the prior year.
  • Liabilities and Shareholders Equity was $1.4 billion for Q4 2024 at Cresco Labs, roughly flat from $1.4 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.4 billion in Q4 2023 and bottomed at $1.3 billion in Q4 2020.
  • Average Liabilities and Shareholders Equity over 3 years is $1.4 billion, with a median of $1.4 billion recorded in 2024.
  • The sharpest move saw Liabilities and Shareholders Equity skyrocketed 118.13% in 2020, then fell 0.23% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $1.3 billion in 2020, then rose by 1.01% to $1.4 billion in 2023, then fell by 0.23% to $1.4 billion in 2024.
  • Business Quant data shows Liabilities and Shareholders Equity for CRLBF at $1.4 billion in Q4 2024, $1.4 billion in Q4 2023, and $1.3 billion in Q4 2020.